Company intelligence / Profile preview

ABLE Human Motion

Barcelona, Catalonia, Spainablehumanmotion.com ↗

Ownership: Private
Development stage: Commercial

Overview

The ABLE Exoskeleton has obtained CE Mark under the new Medical Device Regulation for spinal cord injury rehabilitation. Clinical trials in leading European hospitals have shown improved outcomes in gait training tolerance, motor function, and quality of life. The company continues to expand clinical evidence and regulatory approvals to cover additional neurological conditions such as stroke and multiple sclerosis.

Therapeutic areas: Neurology
Modalities: DeviceRobotic exoskeletonNon-pharmacological therapy (rehabilitation)
Industry: Assistive Medical Devices

Partnerships

EIT Healthcollaborations with leading neurorehabilitation hospitals in Germany and Spaindistribution partners in Italy and Poland with plans to expand further across Europe

Beyond the preview

Go deeper on ABLE Human Motion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABLE Human Motion.

Explore the full profile